Insider Trading & Ownership - Degnan Chris

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Degnan Chris
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2023-03-13
Purchase		2023-03-14
08:30 am		Galera Therapeutics Inc.GRTXDegnan Chris
Chief Financial Officer		10,000$1.9593$19,59310,000
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2024-10-08
Option Award		2024-10-09
4:22 pm		N/A
N/A		UroGen Pharma Ltd.URGNDegnan Chris
Chief Financial Officer		87,592$087,592
(Direct)		View
2023-02-25
Option Award		2023-02-28
6:57 pm		N/A
2033-02-24		Galera Therapeutics Inc.GRTXDegnan Chris
Chief Financial Officer		185,000$0185,000
(Direct)		View
2022-02-28
Option Award		2022-03-02
4:05 pm		N/A
2032-02-27		Galera Therapeutics Inc.GRTXDegnan Chris
Chief Financial Officer		135,000$0135,000
(Direct)		View
2021-01-26
Option Award		2021-01-28
4:05 pm		N/A
2031-01-25		Galera Therapeutics Inc.GRTXDegnan Chris
Chief Financial Officer		82,500$082,500
(Direct)		View
2020-01-31
Option Award		2020-02-04
6:02 pm		N/A
2030-01-30		Galera Therapeutics Inc.GRTXDegnan Chris
Chief Financial Officer		74,435$074,435
(Direct)		View
2019-11-06
Option Award		2019-11-08
7:19 pm		N/A
2029-11-05		Galera Therapeutics Inc.GRTXDegnan Chris
Chief Financial Officer		229,513$0229,513
(Direct)		View